Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Certificates Of Analysis, Written GMP Procedures Urged By AHPA, CRN

This article was originally published in The Tan Sheet

Executive Summary

FDA's refusal to allow ingredient certificates of analysis in place of in-process testing will cause verification tests to be repeated, the American Herbal Products Association says in Aug. 11 comments on the dietary supplement Good Manufacturing Practices proposed rule

You may also be interested in...



Supplement GMPs Should Set Dissolution, Disintegration Requirements – USP

Dissolution or disintegration requirements for dietary supplements ought to be mandated by FDA in order to confirm product quality, the U.S. Pharmacopeia says in Aug. 11 comments on the supplement good manufacturing practices proposed rule

Supplement GMPs Should Set Dissolution, Disintegration Requirements – USP

Dissolution or disintegration requirements for dietary supplements ought to be mandated by FDA in order to confirm product quality, the U.S. Pharmacopeia says in Aug. 11 comments on the supplement good manufacturing practices proposed rule

Supplement GMPs Should Set Dissolution, Disintegration Requirements – USP

Dissolution or disintegration requirements for dietary supplements ought to be mandated by FDA in order to confirm product quality, the U.S. Pharmacopeia says in Aug. 11 comments on the supplement good manufacturing practices proposed rule

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095806

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel